Sign in

CIK 0001719406

  • Non-accelerated filer
  • Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822844431
Phone
+1 484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-28 ABRAMS MICHAEL S Chief Financial Officer Grant or award · Restricted Stock Unit +75,000 75,000
2025-02-07 ABRAMS MICHAEL S Chief Financial Officer Grant or award · Stock Option (right to buy) +50,000 50,000

Page 1 of 1 · 2 trades